Literature DB >> 6184208

The analysis and interpretation of DNA distributions measured by flow cytometry.

P N Dean, J W Gray, F A Dolbeare.   

Abstract

A principal use of flow cytometers is for the measurement of fluorescence distributions of cells stained with DNA specific dyes. A large amount of effort has been and is being expended currently in the analysis of these distributions for the fractions of cells in the G1, S, and G2 + M phases. Several methods of analysis have been proposed and are being used; new methods continue to be introduced. Many, if not most, of these methods differ only in the mathematical function used to represent the phases of the cell cycle and represent attempts to fit exactly distributions with known phase fractions or unusual shapes. In this paper we show that these refinements probably are not necessary because of cell staining and sampling variability. This hypothesis was tested by measuring fluorescence distributions for Chinese hamster ovary and KHT mouse sarcoma cells stained with Hoechst-33258, chromomycin A3, propidium iodide, and acriflavine. Our results show that: a) single measurements can result in phase fraction estimates that are in error by as much as 40% for G2 + M phase and 15-20% for G1 and S phases; b) different dyes can yield phase fraction estimates that differ by as much as 40% due to differences in DNA specificity; c) the shapes of fluorescence distributions and their interpretation are very dependent on the dye being used and on its binding mechanism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184208     DOI: 10.1002/cyto.990030309

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  11 in total

1.  The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures.

Authors:  J M Coco-Martin; J W Oberink; T A van der Velden-de Groot; E C Beuvery
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes.

Authors:  B L Davidson; J Faust; S Pessano; R P Daniele; G Rovera
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Modification of the BrdU/H33258 technique for flow cytometry based on the pH-dependence of the fluorescence of H33258 stained DNA.

Authors:  W Kroll
Journal:  Histochemistry       Date:  1984

4.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.

Authors:  D J Richel; L P Colly; E Lurvink; R Willemze
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

6.  The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.

Authors:  I Yamada; S Seki; S Ito; S Suzuki; O Matsubara; T Kasuga
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

7.  The effect of the G1-S transition checkpoint on an age structured cell cycle model.

Authors:  Gary S Chaffey; David J B Lloyd; Anne C Skeldon; Norman F Kirkby
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Cellular kinetics in rectal cancer.

Authors:  N H Terry; M L Meistrich; L D Roubein; P M Lynch; R A Dubrow; T A Rich
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.

Authors:  T Maeda; S Fuchimoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1988-09

10.  Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression.

Authors:  M Muro; Y Naomoto; K Orita
Journal:  Jpn J Cancer Res       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.